{"entity":{"type":"insider","cik":"0001831127","url":"/insider/0001831127","json_url":"/insider/0001831127.json","name":"Duncan Gregory Scott","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":6,"first":"2021-04-06","last":"2023-08-18","span_basis":"filed_date"},"name_variants":[{"name":"Duncan Gregory Scott","source":"filing","n_filings":6,"first_seen":"2021-04-06","last_seen":"2023-08-18"}],"transactions":[{"id":8262794,"accession":"0001415889-23-012375","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-23-012375","line_url":"/filing/0001415889-23-012375#line-1","is_derivative":false,"issuer_cik":"0001818844","issuer_name":"Virios Therapeutics, Inc.","issuer_ticker":"VIRI","issuer_name_source":null,"issuer_url":"/issuer/0001818844","owner_cik":"0001831127","owner_name":"Duncan Gregory Scott","owner_display_name":"Duncan Gregory Scott","owner_url":"/insider/0001831127","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":1.2498,"price_display":"1.25","price_state":"stated","total_value":31245.0,"total_display":"31,245.00","total_whole":"31,245","shares_owned_after":57461.0,"shares_owned_after_display":"57,461","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-17","filed_date":"2023-08-18","scope":"insider"},{"id":6339499,"accession":"0001415889-22-005567","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-22-005567","line_url":"/filing/0001415889-22-005567#line-1","is_derivative":false,"issuer_cik":"0001818844","issuer_name":"Virios Therapeutics, Inc.","issuer_ticker":"VIRI","issuer_name_source":null,"issuer_url":"/issuer/0001818844","owner_cik":"0001831127","owner_name":"Duncan Gregory Scott","owner_display_name":"Duncan Gregory Scott","owner_url":"/insider/0001831127","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7500.0,"shares_display":"7,500","price_per_share":4.52,"price_display":"4.52","price_state":"stated","total_value":33900.0,"total_display":"33,900.00","total_whole":"33,900","shares_owned_after":32461.0,"shares_owned_after_display":"32,461","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-23","filed_date":"2022-05-24","scope":"insider"},{"id":5545745,"accession":"0001415889-21-006172","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-21-006172","line_url":"/filing/0001415889-21-006172#line-1","is_derivative":false,"issuer_cik":"0001818844","issuer_name":"Virios Therapeutics, Inc.","issuer_ticker":"VIRI","issuer_name_source":null,"issuer_url":"/issuer/0001818844","owner_cik":"0001831127","owner_name":"Duncan Gregory Scott","owner_display_name":"Duncan Gregory Scott","owner_url":"/insider/0001831127","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":5.523,"price_display":"5.52","price_state":"stated","total_value":27615.0,"total_display":"27,615.00","total_whole":"27,615","shares_owned_after":24961.0,"shares_owned_after_display":"24,961","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-21","filed_date":"2021-12-22","scope":"insider"},{"id":5403870,"accession":"0001104659-21-047486","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-047486","line_url":"/filing/0001104659-21-047486#line-1","is_derivative":false,"issuer_cik":"0001818844","issuer_name":"Virios Therapeutics, Inc.","issuer_ticker":"VIRI","issuer_name_source":null,"issuer_url":"/issuer/0001818844","owner_cik":"0001831127","owner_name":"Duncan Gregory Scott","owner_display_name":"Duncan Gregory Scott","owner_url":"/insider/0001831127","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":382.0,"shares_display":"382","price_per_share":6.3576,"price_display":"6.36","price_state":"stated","total_value":2428.6032,"total_display":"2,428.60","total_whole":"2,429","shares_owned_after":19961.0,"shares_owned_after_display":"19,961","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-06","filed_date":"2021-04-07","scope":"insider"},{"id":9223607,"accession":"0001104659-21-047253","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-047253","line_url":"/filing/0001104659-21-047253#line-1","is_derivative":false,"issuer_cik":"0001818844","issuer_name":"Virios Therapeutics, Inc.","issuer_ticker":"VIRI","issuer_name_source":null,"issuer_url":"/issuer/0001818844","owner_cik":"0001831127","owner_name":"Duncan Gregory Scott","owner_display_name":"Duncan Gregory Scott","owner_url":"/insider/0001831127","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15675.0,"shares_display":"15,675","price_per_share":6.1727,"price_display":"6.17","price_state":"stated","total_value":96757.0725,"total_display":"96,757.07","total_whole":"96,757","shares_owned_after":19579.0,"shares_owned_after_display":"19,579","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-05","filed_date":"2021-04-06","scope":"insider"},{"id":4876077,"accession":"0001104659-21-047069","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-047069","line_url":"/filing/0001104659-21-047069#line-1","is_derivative":false,"issuer_cik":"0001818844","issuer_name":"Virios Therapeutics, Inc.","issuer_ticker":"VIRI","issuer_name_source":null,"issuer_url":"/issuer/0001818844","owner_cik":"0001831127","owner_name":"Duncan Gregory Scott","owner_display_name":"Duncan Gregory Scott","owner_url":"/insider/0001831127","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15675.0,"shares_display":"15,675","price_per_share":6.1727,"price_display":"6.17","price_state":"stated","total_value":96757.0725,"total_display":"96,757.07","total_whole":"96,757","shares_owned_after":19579.0,"shares_owned_after_display":"19,579","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-05","filed_date":"2021-04-06","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001818844","name":"Virios Therapeutics, Inc.","url":"/issuer/0001818844","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","n_filings":6,"first_seen":"2021-04-06","last_seen":"2023-08-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001831127","retrieved_at":"2026-08-27T07:48:16+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}